Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 857 results for "mylan"

EMA accepts marketing application of Biocon, Mylan product

Biotech major Biocon today said European Medicines Agency (EMA) has accepted for review Mylan's marketing authorisation application for their biosimilar product Pegfilgrastim, which is used to reduce the duration of neutropenia for cancer patients. ... Business Standard, 1 week ago

281 images for mylan

American Banking News, 1 day ago
SleekMoney, 1 day ago
Financial Buzz, 1 day ago
Yahoo! Singapore, 1 day ago
Broadway World, 1 day ago
Reuters India, 3 days ago
StartupNation, 5 days ago
Share Market Updates, 1 day ago
BigNews.biz, 1 week ago
businessinsider.com, 3 days ago
India Infoline

Biocon provides update on its biosimilar Pegfilgrastim

Co-developed with Mylan
 Business Standard1 week ago Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting  Money Control1 month ago Biocon partners FUJIFILM Pharma to launch Insulin Glargine in Japan  India Infoline2 weeks ago Biocon's partner FUJIFILM launches insulin glargine in Japan  Livemint.com2 weeks ago
[x]  
BioSpace

Mylan introduces temozolomide capsules in US market

Mylan N.V. , a global pharmaceutical company, announced the US launch of temozolomide capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg, which is a generic version of Merck's Temodar. Mylan received final approval from the US Food and Drug ...
 PharmaBiz2 weeks ago Mylan Unveils Generic Temodar Capsules  Benzinga.com2 weeks ago Mylan launches Temozolomide Capsules in U.S.  Seeking Alpha2 weeks ago Mylan Launches Generic Version Of Merck's Temodar - Quick Facts  Quotenet.com2 weeks ago
[x]  
Business Standard

Natco Pharma extends Friday's rally

on BSE, with the stock extending Friday's rally triggered by the company's announcement that its marketing partner, Mylan Inc. has received a tentative approval from USFDA for a drug. Meanwhile, the S BSE Sensex was down 16.20 points or 0.06% at 26,826.83. On ...
 Business Standard1 month ago Natco jumps 9% as partner Mylan Inc gets USFDA nod  Business Standard1 month ago Natco Pharma jumps as partner gets USFDA tentative approval for Sorafenib Tablets  Business Standard1 month ago Natco Pharma's stock jumps over 9% as partner MylanInc gets USFDA nod for cancer drug  DNA1 month ago
[x]  
Business Standard

Mylan presents comparability data for trastuzumab biosimilar

Generics giant Mylan Pharmaceuticals (Mylan) presented robust data from its biosimilar trastuzumab programme at the American Society of Clinical Oncology (ASCO) Annual Meeting ASCO 2016 held in Chicago, USA on 37
 GaBi Online4 weeks ago Mylan, Biocon upbeat on trial data involving breast cancer drug  Business Line1 month ago Biocon upbeat on new cancer drug to tap $7-billion market  Business Line1 month ago Mylan, Biocon India confirm efficacy of trastuzumab  Deccan Herald1 month ago
[x]  

Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Mylan, lopinavir/ritonavir, Revision: 1, Authorised

This is a summary of the European public assessment report (EPAR) for Lopinavir/Ritonavir Mylan. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide ...
 European Medicines Agency3 weeks ago

Indian co might buy Teva product lines for $1.5b - report

Novartis and Mylan are also reportedly interested in acquiring the lines, reports "Bloomberg." The delays in completing Teva Pharmaceutical Industries Ltd.'s (NYSE: TEVA ; TASE: TEVA ) acquisition of Allergan's generic division are affecting the ...
 Globes3 weeks ago Wed: Teva soars as TASE gains  Globes2 weeks ago Thu: Tel Aviv 25 Index up 1% on week  Globes3 weeks ago

Circuit revives Bristol-Myers lawsuit over AIDS drug distribution deal

A federal appeals court revived a lawsuit by Bristol-Myers Squibb Co accusing Indian generic drug maker Mylan Laboratories Ltd of breaching an agreement to distribute a generic version of an AIDS drug in developing countries. A unanimous ...
 Pharmaceutical Tech.com3 weeks ago

Mylan offers EC concessions to get approval for $7.2 billion Meda buy

BRUSSELS - U.S. generic drugmaker Mylan NV ( MYL.O ) has offered concessions in a bid to allay concerns by EU competition regulators over its proposed $7.2-billion acquisition of Swedish rival Meda ( MEDAa.ST ), the European Commission said on ...
 Reuters India4 weeks ago

Mylan Becomes #23 Most Shorted Nasdaq 100 Component, Replacing Dollar Tree

| CEOWORLD Financial | Chief Executive Forum Register Now Lost Password Lost your password? Please enter your email address. You will receive a link and will create a new password via email. July 13, 2016 at 15:02 PM EDT ...
 CEOWorld Magazine2 weeks ago Autodesk Becomes #21 Most Shorted Nasdaq 100 Component, Replacing Mylan  Forbes.com1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - mylan
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less